June 26 (Reuters) - Prima Biomed Ltd (PRR)
- Operational update
- Says is pleased to advise that clinical studies of IMP321 are progressing well
- Says final results of 15 patients from safety run-in phase of aipac are expected in q4 of 2017
- Says data from three cohorts related to the tacti-mel trial is expected in h1 2018
- Forums
- ASX - By Stock
- IMM
- News: PRR Prima BioMed says clinical studies of IMP321 are progressing well
News: PRR Prima BioMed says clinical studies of IMP321 are progressing well
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $522.9M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 35.5¢ | $299.2K | 829.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 32681 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 38380 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 72729 | 0.360 |
23 | 143229 | 0.355 |
14 | 223663 | 0.350 |
9 | 83495 | 0.345 |
8 | 98600 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 41883 | 14 |
0.370 | 148569 | 11 |
0.375 | 82661 | 9 |
0.380 | 112967 | 7 |
0.385 | 125362 | 7 |
Last trade - 15.11pm 26/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |